tradingkey.logo


tradingkey.logo


Smith & Nephew PLC

SNN
33.570USD
-0.610-1.79%
終倀 01/09, 16:00ET15分遅れの株䟡
14.70B時䟡総額
29.87盎近12ヶ月PER


Smith & Nephew PLC

33.570
-0.610-1.79%

詳现情報 Smith & Nephew PLC 䌁業名

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Smith & Nephew PLCの䌁業情報


䌁業コヌドSNN
䌚瀟名Smith & Nephew PLC
䞊堎日Sep 18, 2087
最高経営責任者「CEO」Nath (Deepak S)
埓業員数17349
蚌刞皮類Depository Receipt
決算期末Sep 18
本瀟所圚地Building 5
郜垂WATFORD
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United Kingdom
郵䟿番号WD18 8YE
電話番号4401923477100
りェブサむトhttps://www.smith-nephew.com/
䌁業コヌドSNN
䞊堎日Sep 18, 2087
最高経営責任者「CEO」Nath (Deepak S)

Smith & Nephew PLCの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
+18460.00%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
+3000.00%
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
+2800.00%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+25.00%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+25.00%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+305.00%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+12.00%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+29.00%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+23.00%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
+18460.00%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
+3000.00%
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
+2800.00%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+25.00%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+25.00%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+305.00%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
他の
1.90B
32.62%
地域別USD
䌚瀟名
収益
比率
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
他の
1.90B
32.62%

株䞻

曎新時刻: Tue, Nov 18
曎新時刻: Tue, Nov 18
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
他の
97.55%
株䞻統蚈
株䞻統蚈
比率
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
他の
97.55%
皮類
株䞻統蚈
比率
Investment Advisor
3.66%
Research Firm
2.01%
Investment Advisor/Hedge Fund
1.51%
Hedge Fund
0.27%
Family Office
0.17%
Family Office
0.17%
Pension Fund
0.15%
Family Office
0.12%
Individual Investor
0.01%
他の
91.94%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
443
32.30M
7.60%
-9.85M
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
BMO Capital Markets (US)
3.23M
0.76%
+39.22K
+1.23%
Sep 30, 2025
River Road Asset Management, LLC
2.78M
0.66%
-395.10K
-12.43%
Sep 30, 2025
Scharf Investments, LLC
2.03M
0.48%
-54.46K
-2.61%
Sep 30, 2025
Brandes Investment Partners, L.P.
1.25M
0.29%
-354.20K
-22.08%
Sep 30, 2025
Optiver Holding B.V.
1.10M
0.26%
-50.95K
-4.43%
Sep 30, 2025
Goldman Sachs Asset Management, L.P.
1.09M
0.26%
+15.72K
+1.46%
Sep 30, 2025
Parametric Portfolio Associates LLC
1.02M
0.24%
+43.83K
+4.51%
Sep 30, 2025
BNP Paribas Securities Corp. North America
937.94K
0.22%
+293.42K
+45.52%
Sep 30, 2025
BofA Global Research (US)
862.28K
0.2%
+615.93K
+250.03%
Sep 30, 2025
Morgan Stanley & Co. LLC
770.49K
0.18%
-53.07K
-6.44%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Brandes International ETF
1.07%
ALPS Disruptive Technologies ETF
0.93%
ActivePassive International Equity ETF
0.2%
Avantis Responsible International Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.11%
Avantis International Equity ETF
0.07%
DFA Dimensional International Core Equity 2 ETF
0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
比率1.07%
ALPS Disruptive Technologies ETF
比率0.93%
ActivePassive International Equity ETF
比率0.2%
Avantis Responsible International Equity ETF
比率0.12%
SP Funds S&P World (ex-US) ETF
比率0.11%
Avantis International Equity ETF
比率0.07%
DFA Dimensional International Core Equity 2 ETF
比率0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
比率0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
比率0.01%
SGI Enhanced Global Income ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 1.31B 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
Aug 05, 2025
SNN.NB Final Cash Dividend of gross USD 0.3 paid on Nov 07, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Nov 07, 2025
Oct 03, 2025
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
詳现を芋る

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Smith & Nephew PLCの䞊䜍5名の株䞻は誰ですか


Smith & Nephew PLCの䞊䜍5名の株䞻は以䞋のずおりです。
BMO Capital Markets (US)は3.23M株を保有しおおり、これは党䜓の0.76%に盞圓したす。
River Road Asset Management, LLCは2.78M株を保有しおおり、これは党䜓の0.66%に盞圓したす。
Scharf Investments, LLCは2.03M株を保有しおおり、これは党䜓の0.48%に盞圓したす。
Brandes Investment Partners, L.P.は1.25M株を保有しおおり、これは党䜓の0.29%に盞圓したす。
Optiver Holding B.V.は1.10M株を保有しおおり、これは党䜓の0.26%に盞圓したす。

Smith & Nephew PLCの株䞻タむプ䞊䜍3皮は䜕ですか


Smith & Nephew PLCの株䞻タむプ䞊䜍3皮は、
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC

Smith & Nephew PLCSNNの株匏を保有しおいる機関の数はいく぀ですか


2025Q4時点で、Smith & Nephew PLCの株匏を保有しおいる機関は443瀟あり、保有株匏の総垂堎䟡倀は玄32.30Mで、党䜓の7.60%を占めおいたす。2025Q3ず比范しお、機関の持ち株は-0.12%増加しおいたす。

Smith & Nephew PLCの最倧の収益源は䜕ですか


FY2024においお、Sports Medicine Joint Repair郚門がSmith & Nephew PLCにずっお最倧の収益を生み出しおおり、その金額は982.00Mで、党収益の16.90%を占めおいたす。
KeyAI
î™